Phase I study of combination chemotherapy with irinotecan hydrochloride and nedaplatin for cervical squamous cell carcinoma: Japanese gynecologic oncology group study

Yamamoto

doi:10.3892/or_00000316

Phase I study of combination chemotherapy with irinotecan hydrochloride and nedaplatin for cervical squamous cell carcinoma: Japanese gynecologic oncology group study

Oncology Reports ◽

10.3892/or_00000316 ◽

2009 ◽

Vol 21 (4) ◽

Cited By ~ 22

Author(s):

Yamamoto

Keyword(s):

Squamous Cell Carcinoma ◽

Phase I ◽

Combination Chemotherapy ◽

Phase I Study ◽

Gynecologic Oncology ◽

Cervical Squamous Cell Carcinoma ◽

Gynecologic Oncology Group ◽

Oncology Group ◽

Oncology Group Study ◽

Irinotecan Hydrochloride

Download Full-text

Phase II study of neoadjuvant chemotherapy with irinotecan hydrochloride and nedaplatin followed by radical hysterectomy for bulky stage Ib2 to IIb, cervical squamous cell carcinoma: Japanese Gynecologic Oncology Group study (JGOG 1065)

Oncology Reports ◽

10.3892/or.2012.1814 ◽

2012 ◽

Vol 28 (2) ◽

pp. 487-493 ◽

Cited By ~ 23

Author(s):

SATOSHI YAMAGUCHI ◽

RYUICHIRO NISHIMURA ◽

NOBUO YAEGASHI ◽

KAZUSHIGE KIGUCHI ◽

TORU SUGIYAMA ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Neoadjuvant Chemotherapy ◽

Radical Hysterectomy ◽

Phase Ii Study ◽

Gynecologic Oncology ◽

Cervical Squamous Cell Carcinoma ◽

Gynecologic Oncology Group ◽

Oncology Group ◽

Oncology Group Study ◽

Irinotecan Hydrochloride

Download Full-text

A phase I study of paclitaxel, topotecan, cisplatin and Filgrastim in patients with newly diagnosed advanced ovarian epithelial malignancies: A Gynecologic Oncology Group study

Gynecologic Oncology ◽

10.1016/j.ygyno.2007.01.039 ◽

2007 ◽

Vol 105 (3) ◽

pp. 667-671 ◽

Cited By ~ 10

Author(s):

Deborah K. Armstrong ◽

Michael A. Bookman ◽

William McGuire ◽

Robert E. Bristow ◽

Jeanne M. Schilder

Keyword(s):

Phase I ◽

Phase I Study ◽

Gynecologic Oncology ◽

Gynecologic Oncology Group ◽

Newly Diagnosed ◽

Oncology Group ◽

Oncology Group Study

Download Full-text

A phase I study of continuous veliparib in combination with IV carboplatin/paclitaxel or IV/IP paclitaxel/cisplatin and bevacizumab in newly diagnosed patients with previously untreated epithelial ovarian, fallopian tube, or primary peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study.

Journal of Clinical Oncology ◽

10.1200/jco.2015.33.15_suppl.5507 ◽

2015 ◽

Vol 33 (15_suppl) ◽

pp. 5507-5507 ◽

Cited By ~ 15

Author(s):

Katherine M. Bell-McGuinn ◽

William E Brady ◽

Russell J. Schilder ◽

Paula M Fracasso ◽

Kathleen N. Moore ◽

...

Keyword(s):

Phase I ◽

Fallopian Tube ◽

Phase I Study ◽

Gynecologic Oncology ◽

Gynecologic Oncology Group ◽

Newly Diagnosed ◽

Oncology Group ◽

Oncology Group Study ◽

Primary Peritoneal Cancer ◽

Peritoneal Cancer

Download Full-text

A phase I study with an expanded cohort to assess the feasibility of intraperitoneal carboplatin and intravenous paclitaxel in untreated ovarian, fallopian tube, and primary peritoneal carcinoma: A Gynecologic Oncology Group study

Gynecologic Oncology ◽

10.1016/j.ygyno.2010.12.358 ◽

2011 ◽

Vol 121 (2) ◽

pp. 264-268 ◽

Cited By ~ 16

Author(s):

Mark A. Morgan ◽

Michael W. Sill ◽

Keiichi Fujiwara ◽

Benjamin Greer ◽

Stephen C. Rubin ◽

...

Keyword(s):

Phase I ◽

Fallopian Tube ◽

Phase I Study ◽

Gynecologic Oncology ◽

Gynecologic Oncology Group ◽

Oncology Group ◽

Peritoneal Carcinoma ◽

Oncology Group Study ◽

Primary Peritoneal Carcinoma

Download Full-text

A phase I study of IV doxorubicin plus intraperitoneal (IP) paclitaxel and IV or IP cisplatin in endometrial cancer patients at high risk for peritoneal failure (GOG 9920): An NRG Oncology/Gynecologic Oncology Group study

Gynecologic Oncology ◽

10.1016/j.ygyno.2015.04.038 ◽

2015 ◽

Vol 138 (1) ◽

pp. 36-40 ◽

Cited By ~ 4

Author(s):

D. Scott McMeekin ◽

Michael W. Sill ◽

Joan L. Walker ◽

Kathleen N. Moore ◽

Steven E. Waggoner ◽

...

Keyword(s):

Endometrial Cancer ◽

High Risk ◽

Phase I ◽

Cancer Patients ◽

Phase I Study ◽

Gynecologic Oncology ◽

Gynecologic Oncology Group ◽

Oncology Group ◽

Oncology Group Study

Download Full-text

A phase I study with an expanded cohort to assess feasibility of intravenous docetaxel, intraperitoneal carboplatin and intraperitoneal paclitaxel in patients with previously untreated ovarian, fallopian tube or primary peritoneal carcinoma: A Gynecologic Oncology Group study

Gynecologic Oncology ◽

10.1016/j.ygyno.2012.08.037 ◽

2012 ◽

Vol 127 (3) ◽

pp. 506-510 ◽

Cited By ~ 8

Author(s):

Natalie Gould ◽

Michael W. Sill ◽

Robert S. Mannel ◽

Premal H. Thaker ◽

Paul A. DiSilvestro ◽

...

Keyword(s):

Phase I ◽

Fallopian Tube ◽

Phase I Study ◽

Gynecologic Oncology ◽

Gynecologic Oncology Group ◽

Oncology Group ◽

Peritoneal Carcinoma ◽

Oncology Group Study ◽

Primary Peritoneal Carcinoma

Download Full-text

A phase I study with an expanded cohort to assess the feasibility of intravenous paclitaxel, intraperitoneal carboplatin and intraperitoneal paclitaxel in patients with untreated ovarian, fallopian tube or primary peritoneal carcinoma: A Gynecologic Oncology Group study

Gynecologic Oncology ◽

10.1016/j.ygyno.2011.12.417 ◽

2012 ◽

Vol 125 (1) ◽

pp. 54-58 ◽

Cited By ~ 5

Author(s):

Natalie Gould ◽

Michael W. Sill ◽

Robert S. Mannel ◽

P.H. Thaker ◽

Paul DiSilvestro ◽

...

Keyword(s):

Phase I ◽

Fallopian Tube ◽

Phase I Study ◽

Gynecologic Oncology ◽

Gynecologic Oncology Group ◽

Oncology Group ◽

Peritoneal Carcinoma ◽

Oncology Group Study ◽

Primary Peritoneal Carcinoma

Download Full-text

Phase II trials of cisplatin and piperazinedione in advanced or recurrent squamous cell carcinoma of the vulva: A gynecologic oncology group study

Gynecologic Oncology ◽

10.1016/0090-8258(86)90138-1 ◽

1986 ◽

Vol 23 (3) ◽

pp. 358-363 ◽

Cited By ~ 22

Author(s):

J.Tate Thigpen ◽

John A. Blessing ◽

Howard D. Homesley ◽

George C. Lewis

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Squamous Cell ◽

Gynecologic Oncology ◽

Gynecologic Oncology Group ◽

Oncology Group ◽

Phase Ii Trials ◽

Oncology Group Study ◽

Recurrent Squamous Cell Carcinoma

Download Full-text

Evaluation of vinorelbine in persistent or recurrent squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study

Gynecologic Oncology ◽

10.1016/j.ygyno.2003.10.045 ◽

2004 ◽

Vol 92 (2) ◽

pp. 639-643 ◽

Cited By ~ 32

Author(s):

Franco M Muggia ◽

John A Blessing ◽

Michael Method ◽

David Scott Miller ◽

Gary A Johnson ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Squamous Cell ◽

Gynecologic Oncology ◽

Gynecologic Oncology Group ◽

Oncology Group ◽

Oncology Group Study ◽

Recurrent Squamous Cell Carcinoma

Download Full-text

A Phase I Trial of Prolonged Oral Etoposide and Liposomal Doxorubicin in Ovarian, Peritoneal, and Tubal Carcinoma: A Gynecologic Oncology Group Study

Gynecologic Oncology ◽

10.1006/gyno.2002.6584 ◽

2002 ◽

Vol 85 (1) ◽

pp. 136-139 ◽

Cited By ~ 7

Author(s):

Peter G. Rose ◽

Michael Rodriguez ◽

Joan Walker ◽

Benjamin Greer ◽

Nancy Fusco ◽

...

Keyword(s):

Phase I ◽

Phase I Trial ◽

Liposomal Doxorubicin ◽

Gynecologic Oncology ◽

Gynecologic Oncology Group ◽

Oral Etoposide ◽

Oncology Group ◽

Oncology Group Study

Download Full-text